Date Announcement
30/12/2022 Application for quotation of securities
09/12/2022 Corporate Update and Acquisition
29/11/2022 Amended Constitution
29/11/2022 CEO’s AGM Address
29/11/2022 Final Directors Interest Notice – Eck
29/11/2022 Results of Annual General Meeting
28/10/2022 Notice of Annual General Meeting/Proxy Form
26/10/2022 Appendix 4C and Quarterly Activity Report
17/10/2022 Director Resignation – Dennis Eck
23/09/2022 Annual Report to Shareholders
23/09/2022 Appendix 4G and Corporate Governance Statement
16/09/2022 Change of Director’s Interest Notice – Greasley
25/08/2022 Appendix 4E and FY22 Financial Report
26/07/2022 Advangen Japan Divestment and Earn-Out Agreement
26/07/2022 Appendix 4C and Quarterly Activity Report
08/07/2022 Appointment of Exec Director, Corporate and Trading Update
08/07/2022 Initial Director’s Interest Notice – Greasley
28/04/2022 Appendix 4C and Quarterly Activity Report
16/03/2022 New Leadership Driving Business Transformation
02/03/2022 Notification of cessation of securities – AN1
01/03/2022 Anagenics Appoints CEO
01/03/2022 Final Director’s Interest Notice – Halasz
15/02/2022 Anagenics Board and Leadership Transition
15/02/2022 Appendix 4D and Half Year Report
15/02/2022 Final Director’s Interest Notice – Gordon
15/02/2022 Initial Director’s Interest Notice – Beard
02/02/2022 Change of Director’s Interest Notice – Halasz
28/01/2022 Appendix 4C and Quarterly Activity Report
20/01/2022 Change in substantial holding from HNG
07/01/2022 Application for quotation of securities – AN1
07/01/2022 Change of Director’s Interest Notice – DE
07/01/2022 Cleansing Notice
07/01/2022 Release of Shares from Voluntary Escrow

Let’s get in touch

Got a question? Email us

    Register for Investor Alerts